Elevated serum lysophosphatidylcholine in patients with systemic lupus erythematosus impairs phagocytosis of necrotic cells in vitro

Grossmayer GE, Keppeler H, Böltz S, Janko C, Rech J, Herrmann M, Lauber K, Munoz LE (2018)

Publication Status: Published

Publication Type: Journal article, Original article

Publication year: 2018

Journal

Frontiers in Immunology Frontiers Research Foundation / Frontiers Media

Publisher: Frontiers Media S.A.

Book Volume: 8

Article Number: 1876

DOI: 10.3389/fimmu.2017.01876

Authors with CRIS profile

Sebastian Böltz Department of Medicine 3 – Rheumatology and Immunology Christina Janko Einrichtungen, die zum Universitätsklinikum Erlangen gehören Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology Martin Herrmann Department of Medicine 3 – Rheumatology and Immunology Luis Munoz Becerra Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Eberhard Karls Universität Tübingen DE Germany (DE)

How to cite

APA:

Grossmayer, G.E., Keppeler, H., Böltz, S., Janko, C., Rech, J., Herrmann, M.,... Munoz, L.E. (2018). Elevated serum lysophosphatidylcholine in patients with systemic lupus erythematosus impairs phagocytosis of necrotic cells in vitro. Frontiers in Immunology, 8. https://doi.org/10.3389/fimmu.2017.01876

MLA:

Grossmayer, Gerhard E., et al. "Elevated serum lysophosphatidylcholine in patients with systemic lupus erythematosus impairs phagocytosis of necrotic cells in vitro." Frontiers in Immunology 8 (2018).

BibTeX: Download